DK113886A - Fremgangsmaade til fremstilling af heparansulfat og dermatansulfat ogfarmaceutisk anvendelse af disse stoffer - Google Patents

Fremgangsmaade til fremstilling af heparansulfat og dermatansulfat ogfarmaceutisk anvendelse af disse stoffer Download PDF

Info

Publication number
DK113886A
DK113886A DK113886A DK113886A DK113886A DK 113886 A DK113886 A DK 113886A DK 113886 A DK113886 A DK 113886A DK 113886 A DK113886 A DK 113886A DK 113886 A DK113886 A DK 113886A
Authority
DK
Denmark
Prior art keywords
sulphate
dermatan
heparan
substances
procedure
Prior art date
Application number
DK113886A
Other languages
Danish (da)
English (en)
Other versions
DK113886D0 (da
Inventor
Rinaldo Del Bono
Luigi De Ambrosi
Piergiuseppe Pagella
Gianni Ferrari
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Publication of DK113886D0 publication Critical patent/DK113886D0/da
Publication of DK113886A publication Critical patent/DK113886A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0066—Isolation or extraction of proteoglycans from organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK113886A 1985-03-13 1986-03-12 Fremgangsmaade til fremstilling af heparansulfat og dermatansulfat ogfarmaceutisk anvendelse af disse stoffer DK113886A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8519885A IT1208509B (it) 1985-03-13 1985-03-13 Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.

Publications (2)

Publication Number Publication Date
DK113886D0 DK113886D0 (da) 1986-03-12
DK113886A true DK113886A (da) 1986-09-14

Family

ID=11162062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK113886A DK113886A (da) 1985-03-13 1986-03-12 Fremgangsmaade til fremstilling af heparansulfat og dermatansulfat ogfarmaceutisk anvendelse af disse stoffer

Country Status (20)

Country Link
US (1) US4783447A (el)
EP (1) EP0199033B1 (el)
JP (1) JPS61218601A (el)
KR (1) KR910006809B1 (el)
AT (1) ATE99702T1 (el)
AU (1) AU582221B2 (el)
CA (1) CA1286286C (el)
DE (1) DE3689493T2 (el)
DK (1) DK113886A (el)
ES (1) ES8705894A1 (el)
FI (1) FI82700C (el)
GR (1) GR860677B (el)
IN (1) IN163616B (el)
IT (1) IT1208509B (el)
NO (1) NO166187C (el)
NZ (1) NZ215435A (el)
PH (2) PH22370A (el)
PT (1) PT82198B (el)
YU (1) YU46303B (el)
ZA (1) ZA861855B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1189085B (it) * 1986-03-25 1988-01-28 Mediolanum Farmaceutici Srl Processo per la preparazione di dermatan solfato ad alta purezza e composizioni farmaceutiche che lo contengono
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
DE3639561A1 (de) * 1986-11-20 1988-06-01 Baumann Hanno Verfahren zur herstellung von nicht-thrombogenen substraten
IT1232939B (it) * 1987-11-06 1992-03-10 Opocrin Spa Eparan solfato caratterizzato da elevata attivita' antitrombotica, elevata biodisponibilita', assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche
DE68909412T2 (de) * 1988-06-03 1994-02-03 Italfarmaco Spa Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
EP0421508B1 (en) * 1989-10-04 1993-12-15 Akzo Nobel N.V. Sulphated glycosaminoglycuronan with antithrombotic activity
EP0493533A4 (en) * 1989-10-27 1992-10-28 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
AU7742591A (en) * 1990-04-06 1991-10-30 Washington University Anticoagulant oligosaccharides
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
FR2691066B1 (fr) * 1992-05-15 1995-06-09 Sanofi Elf Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
PL177245B1 (pl) * 1993-09-30 1999-10-29 Seikagaku Kogyo Co Ltd Środek przeciwzakrzepowy
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
IT1296581B1 (it) * 1997-11-28 1999-07-14 Istituto Scient Di Chimica E B Materiali polimerici non trombogenici e ad esaltata compatibilita' con fluidi e tessuti organici
HUP0201712A3 (en) * 1999-06-30 2003-03-28 Weitz Jeffrey I Ancaster Clot associated coagulation factors inhibiting heparin compositions
EP1315539A2 (en) * 2000-09-08 2003-06-04 Leo Pharma A/S Antithrombotic compositions
CN107098989A (zh) * 2017-04-27 2017-08-29 甘肃省金羚集团药业有限公司 一种肝素钠的制备方法
CN114478832B (zh) * 2022-02-14 2023-03-03 河北常山生化药业股份有限公司 从肝素钠副产物中提纯四种多糖类产品的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179566A (en) * 1963-05-16 1965-04-20 Canada Packers Ltd Purification of heparin
JPS5318520B2 (el) * 1972-07-05 1978-06-15
AR207237A1 (es) * 1974-02-25 1976-09-22 Thomas A Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
JPS58171403A (ja) * 1982-04-01 1983-10-08 Eisai Co Ltd ヘパラン硫酸の精製法
IT1189298B (it) * 1982-06-18 1988-02-04 Manetti & Roberts Italo Brit Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
FR2555993B1 (fr) * 1983-12-06 1986-11-07 Anic Spa Chitosanes 6-sulfates et procede pour leur preparation
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
IT1163772B (it) * 1983-07-13 1987-04-08 Baldacci Lab Spa Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
ES552898A0 (es) 1987-05-16
PH25136A (en) 1991-02-19
AU5472786A (en) 1986-09-18
US4783447A (en) 1988-11-08
GR860677B (en) 1986-07-14
YU37586A (en) 1988-04-30
AU582221B2 (en) 1989-03-16
ES8705894A1 (es) 1987-05-16
DE3689493T2 (de) 1994-04-28
PH22370A (en) 1988-08-12
EP0199033A3 (en) 1988-03-30
ZA861855B (en) 1986-10-29
NO166187B (no) 1991-03-04
NO860940L (no) 1986-09-15
YU46303B (sh) 1993-05-28
KR860007278A (ko) 1986-10-10
DK113886D0 (da) 1986-03-12
JPS61218601A (ja) 1986-09-29
PT82198A (en) 1986-04-01
KR910006809B1 (ko) 1991-09-02
FI82700C (fi) 1991-04-10
PT82198B (pt) 1988-02-17
NO166187C (no) 1991-06-12
CA1286286C (en) 1991-07-16
ATE99702T1 (de) 1994-01-15
IN163616B (el) 1988-10-15
FI861020A (fi) 1986-09-14
IT1208509B (it) 1989-07-10
NZ215435A (en) 1989-01-06
FI861020A0 (fi) 1986-03-12
JPH0238601B2 (el) 1990-08-31
EP0199033B1 (en) 1994-01-05
FI82700B (fi) 1990-12-31
IT8519885A0 (it) 1985-03-13
DE3689493D1 (de) 1994-02-17
EP0199033A2 (en) 1986-10-29

Similar Documents

Publication Publication Date Title
DK113886A (da) Fremgangsmaade til fremstilling af heparansulfat og dermatansulfat ogfarmaceutisk anvendelse af disse stoffer
FI103381B1 (fi) Hyaluronihapon veteen liukenemattomia geelejä ja menetelmä sen valmistamiseksi
DK372186D0 (da) Polysaccharidpolymer samt fremgangsmaade til fremstilling heraf og mikrobiologisk ren xanthomonas-kultur
BR9711117A (pt) Oligossacarídios modificados.
IT1230582B (it) Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
CA2285383A1 (en) Glycosaminoglycans having high antithrombotic activity
DE69033970T2 (de) Huperzin a analoge verbindungen
SE8704062L (sv) Skruvrotormaskin
DE69100943T2 (de) Mit metallischen schuppen oder metallisierten flocken versehene dekorfolie insbesondere zur herstellung von schichtstoffplatten.
IE902276L (en) Serpin variants
ATE332706T1 (de) Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen
Murata et al. High-performance liquid chromatographic identification of disaccharides generated from heparan sulphate isomers using heparitinases
NO972303L (no) Intravenöse lubeluzollösninger
DE3885012D1 (de) Fermentationsverfahren zur Herstellung eines Polysaccharids wie Xanthan.
IT8423664A0 (it) Realizzate in applicazione al detto metodo per la produzione metodo. industriale di calzature, in particolare ciabatte, di notevole leggerezza ed utilizzabili sia da casa che all'aperto, e calzature
BG102009A (en) Method for the treatment of manic and two-pole disease
ES293667U (es) Estructura espacial para formacion de cupulas y bovedas ligeras medias y pesadas

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment